China SXT Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
China SXT Pharmaceuticals has a total shareholder equity of $5.1M and total debt of $3.3M, which brings its debt-to-equity ratio to 65.2%. Its total assets and total liabilities are $14.6M and $9.5M respectively.
Key information
65.2%
Debt to equity ratio
US$3.31m
Debt
Interest coverage ratio | n/a |
Cash | US$11.47m |
Equity | US$5.08m |
Total liabilities | US$9.51m |
Total assets | US$14.59m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SXTC's short term assets ($13.5M) exceed its short term liabilities ($9.2M).
Long Term Liabilities: SXTC's short term assets ($13.5M) exceed its long term liabilities ($311.5K).
Debt to Equity History and Analysis
Debt Level: SXTC has more cash than its total debt.
Reducing Debt: SXTC's debt to equity ratio has increased from 9.6% to 65.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SXTC has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: SXTC has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 7.5% each year